Michigan Drug Discovery
  • About
    • What we do
    • Staff
    • Executive Committee
    • MDD Scientific Advisory Board
    • Affiliates
    • Campus Partners
  • Resources
    • Drug Discovery Roadmap
    • Drug Discovery Research Cores
    • Our Funding Opportunities
    • U-M Funding Opportunities
    • Consulting Services
    • External Resources
    • Internal Resources
  • External Partners
  • Highlighted Projects
  • Recent News
  • Contact Us
  • Support Us
Select Page
Protein Misfolding and Neurodegenerative Diseases

Protein Misfolding and Neurodegenerative Diseases

Jan 27, 2020

Project Details Protein Misfolding and Neurodegenerative Diseases Autophagy-inducing compounds to reduce neuron loss in ALS and FTD Autophagy is a critical, evolutionarily conserved pathway mediating the breakdown and recycling of cellular proteins and organelles....

Recent Posts

  • Leukemia treatment based on U-M research gets FDA approval
  • Join us on Wednesday, October 1st, 2025 for the 5th Annual Drug Discovery Symposium!
  • Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
  • Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway
  • A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance
UM Drug Discovery Logo

Michigan Drug Discovery is a campus-spanning program established to mentor, support, identify, and coordinate resources for investigators with an interest in pursuing drug discovery research.

University of Michigan | Michigan Medicine
© Copyright 2019 Regents of the University of Michigan | Privacy Statement | Non-discrimination policy
Nonprofit web design by Boxcar Studio

Michigan Drug Discovery
Mary Sue Coleman Hall
210 Washtenaw Avenue, Rm. 4403
Ann Arbor, MI 48109-2216

Contact Us
Support Us